Barry J. Gertz
- Pharmacology top 0.2%
- Molecular Biology top 5%
- Physiology top 2%
- Surgery top 5%
- Oncology top 5%
- Co-authors
- Arturo G. PorrasSherry D. HollandHui QuanKenneth C. LasseterLee J. MartinRhoda SperlingAlise ReicinMatthew R. Weir
- Topics
- Inflammatory mediators and NSAID effects (22 papers)Pharmacogenetics and Drug Metabolism (10 papers)Eicosanoids and Hypertension Pharmacology (8 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Barry J. Gertz
69 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 141
- Pharmacology 1.9k
- Molecular Biology 1.4k
- Physiology 1.2k
- Surgery 1.0k
- Oncology 899
Countries citing papers authored by Barry J. Gertz
This map shows the geographic impact of Barry J. Gertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry J. Gertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry J. Gertz more than expected).
Fields of papers citing papers by Barry J. Gertz
This network shows the impact of papers produced by Barry J. Gertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry J. Gertz. The network helps show where Barry J. Gertz may publish in the future.
Co-authorship network of co-authors of Barry J. Gertz
This figure shows the co-authorship network connecting the top 25 collaborators of Barry J. Gertz. A scholar is included among the top collaborators of Barry J. Gertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry J. Gertz. Barry J. Gertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 155 | |
| 4 | 45 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 115 | |
| 9 | 86 | |
| 10 | 49 | |
| 11 | 191 | |
| 12 | 49 | |
| 13 | 208 | |
| 14 | 17 | |
| 15 | 28 | |
| 16 | 49 | |
| 17 | 27 | |
| 18 | 50 | |
| 19 | 14 | |
| 20 | 4 |
About Barry J. Gertz
Barry J. Gertz is a scholar working on Pharmacology, Pharmacology and Biochemistry, having authored 69 papers that have together received 5.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (22 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). The work is most often cited by research in Pharmacology (1.9k citations), Biochemistry (630 citations) and Orthopedics and Sports Medicine (612 citations). Barry J. Gertz has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Arturo G. Porras, Sherry D. Holland, Hui Quan, Kenneth C. Lasseter, Lee J. Martin, Rhoda Sperling, Alise Reicin, Matthew R. Weir, D. Craig Brater and Briggs Morrison. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.